MYO1C and prostate cancer: Taken together with this isoform’s specific expression in invasive forms of prostate cancer12, the new data shed additional light on prostate carcinogenesis and identify isoform A of myosin IC as a molecule suitable for a mechanistically grounded development into a marker and target for prognosis, detection, and treatment of invasive prostate cancer.